Chemical Structure : Canlitinib
CAS No.:
2222730-78-9
Canlitinib
(Kanitinib)
Catalog No.: PC-21975Not For Human Use, Lab Use Only.
Canlitinib (Kanitinib) is a multitargeted receptor tyrosine kinase inhibitor targeting the oncoprotein c-Met (hepatocyte growth factor receptor; HGFR; MET) and vascular endothelial growth factor receptor 2 (VEGFR2), with potential anti-angiogenic and antineoplastic activities.
| Packing | Price | Stock | Quantity |
| 5 mg | $218 | In stock | |
| 10 mg | $358 | In stock | |
| 25 mg | $558 | In stock | |
| 50 mg | | Get quote | |
| 100 mg | | Get quote | |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Purity & Documentation Purity:
>98% (HPLC)
Select Batch:
Biological Activity
Canlitinib (Kanitinib) is a multitargeted receptor tyrosine kinase inhibitor targeting the oncoprotein c-Met (hepatocyte growth factor receptor; HGFR; MET) and vascular endothelial growth factor receptor 2 (VEGFR2), with potential anti-angiogenic and antineoplastic activities.
Physicochemical Properties
|
M.Wt
|
619.62
|
|
Formula
|
C33H31F2N3O7
|
|
Appearance
|
Solid
|
|
CAS No.
|
|
|
Storage
|
- Solide Powder
-
-20°C 12 Months; 4°C 6 Months
|
- In Solvent
-
-80°C 6 Months; -20°C 6 Months
|
|
Shipping
|
|
|
Solubility
|
10 mM in DMSO
|
|
Chemical Name/SMILES
|
Hexanoic acid, 6-[[4-[2-fluoro-4-[[[1-[[(4-fluorophenyl)amino]carbonyl]cyclopropyl]carbonyl]amino]phenoxy]-6-methoxy-7-quinolinyl]oxy]-
|
References
1. Patent WO2017-CN104518.
Contact Us
sales@probechem.com
